Abstract

Three novel trinuclear Ni(II) complexes, [Ni3(L1)2(py)4] (1), [Ni3(L2)2(H2O)2(DMA)2] (2) and [Ni3(L3)2(py)4] (3), with trianionic pentadentate ligands derived from salicylhydrazide with N-acyl substituents [H3L1=N2-crotonoylsalicylhydrazide, H3L2=N2-(3,3-dimethylacryloyl)salicylhydrazide, H3L3=N2-cinnamoylsalicylhydrazide] were synthesized and characterized by elemental analysis, spectroscopic techniques, like UV–Vis, FT-IR and NMR, molar conductivity and magnetic susceptibility measurements, and single crystal X-ray diffraction. The solid state structures of the complexes reveal the binding modes of the different ligands via ONO donor atoms. Complex 1 crystallises in the triclinic system while complexes 2 and 3 crystallise in the monoclinic system with space groups P1¯ (1) and P21/c (2 and 3). Computational studies were performed using Density Functional Theory (DFT) to obtain physical properties of all three complexes. The ligands and their metal complexes were screened for antibacterial activity to assess their inhibition potential against two Gram positive bacteria; Staphylococcus aureus and Bacillus subtilis and two Gram negative bacteria; Escherichia coli and Pseudomonas aeruginosa by the well diffusion method using gentamicin as a positive control. Antibacterial screening data reveals that the trinuclear Ni(II) complexes have significantly enhanced inhibitory activities compared to the ligands.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.